Table 4 Univariate and multivariable Cox proportional hazards model for OS
From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
Characteristic | Univariate analysis | Univariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Age | ||||
(≤55 vs. >55) | 1.142 (0.679–1.922) | 0.617 | 0.696 (0.390–1.243) | 0.221 |
Sex | ||||
Female vs. Male | 0.613 (0.360–1.044) | 0.072 | 0.548 (0.309–0.970) | 0.039* |
Location | ||||
Mucosa vs. Skin | 2.611 (1.123–6.070) | 0.026* | 2.046 (0.834–5.020) | 0.118 |
Acral vs. Skin | 1.573 (0.497–4.974) | 0.441 | 1.503 (0.441–5.125) | 0.515 |
Others vs. Skin | 3.222 (1.235–8.407) | 0.017* | 1.933 (0.705–5.304) | 0.200 |
Neuroendocrinea | 1.067 (0.632–1.802) | 0.809 | 1.323 (0.767–2.282) | 0.314 |
BRAF alternations | 0.440 (0.208–0.930) | 0.031* | 0.608 (0.262–1.412) | 0.247 |
Stage | ||||
III vs. I-II | 0.787 (0.297–2.082) | 0.629 | 0.617 (0.222–1.718) | 0.355 |
IV vs. I-II | 4.456 (2.500–7.940) | 0.000*** | 4.194 (2.185–8.050) | 0.000*** |